Clinical Trial Update: A Study of AdCh63 AMA1 Alone and With MVA AMA1 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated AdCh63 AMA1 alone and in combination with MVA AMA1 for malaria; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AdCh63 AMA1 (Chimpanzee adenovirus ChAd63 vector expressing AMA1)
• MVA AMA1 (Modified vaccinia Ankara expressing AMA1)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED